Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

DepoTech initiates pediatric clinical trial DepoCyt

Feb. 28, 1997

Somatostatin peptides prepared by Novartis

Feb. 28, 1997

Yamanouchi prepares hormonal agents for testosterone-dependent disorders

Feb. 28, 1997

Cytotoxic colchicine derivatives from Indena

Feb. 27, 1997

Third pivotal trial for lisofylline

Feb. 26, 1997

New approach to brain cancer introduced

Feb. 26, 1997

U.S. researchers reveal agents for reversing MDR

Feb. 25, 1997

Oxford GlycoSciences describes pyrimidine-based glycoconjugates

Feb. 25, 1997

SCRAS discloses novel topoisomerase inhibitors

Feb. 25, 1997

NIH seeks licensees for cancer vaccines

Feb. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...